000 01576 a2200409 4500
005 20250515091836.0
264 0 _c20080717
008 200807s 0 0 eng d
022 _a0172-8172
024 7 _a10.1007/s00296-007-0468-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPrince, Femke H M
245 0 0 _aInitiating etanercept in a once weekly dose in children with juvenile idiopathic arthritis.
_h[electronic resource]
260 _bRheumatology international
_cFeb 2008
300 _a397-8, author reply 399 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAdolescent
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadministration & dosage
650 0 4 _aArthritis, Juvenile
_xdrug therapy
650 0 4 _aChild
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Therapy, Combination
650 0 4 _aEtanercept
650 0 4 _aFemale
650 0 4 _aGlucocorticoids
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aImmunoglobulin G
_xadministration & dosage
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aPrednisone
_xadministration & dosage
650 0 4 _aReceptors, Tumor Necrosis Factor
_xadministration & dosage
650 0 4 _aTreatment Outcome
700 1 _avan Suijlekom-Smit, Lisette W A
773 0 _tRheumatology international
_gvol. 28
_gno. 4
_gp. 397-8, author reply 399
856 4 0 _uhttps://doi.org/10.1007/s00296-007-0468-5
_zAvailable from publisher's website
999 _c17461063
_d17461063